Abstract
A double blind placebo controlled trial of ispaghula husk in 80 patients with irritable bowel syndrome is reported. Global assessment judged treatment to be satisfactory in 82% of patients receiving ispaghula and 53% of the placebo group (p
Original language | English |
---|---|
Pages (from-to) | 1510-1513 |
Number of pages | 3 |
Journal | Gut |
Volume | 28 |
Issue number | 11 |
DOIs | |
Publication status | Published - 1987 |